Optimizing Clinical and Economic Outcomes with Personalized Treatment in Management of Overactive Bladder (OAB)

A continuing medical education activity sponsored by NAMCP and AAMCN.

This activity is an archive from the live session from the 2019 Fall Managed Care Forum. If you participated in the live session, you are not eligible for continuing education credits from this archive.

This activity is valid from January 1, 2020 to January 1, 2021

Instructions for CME/CNE: Complete the pre-test, listen to the audio and view the slides, complete the post test, complete the evaluation form and hit submit. You will be asked to enter your name and email address on the pre-test, evaluation and post-test. If you close your internet browser without completing the post test, you will have ONE more opportunity to complete. A score of 70% must be achieved on the post test to receive continuing education credits. If you do not pass the post test after two attempts, you will not be eligible to try again. Once you complete the evaluation form and score 70% or higher on your post test, you will automatically be given your certificate.

To print or save your certificate, you will need to click on the “download” button and either print or save.

 

Audience: This activity is intended for healthcare professionals practicing in managed care environments.

This presentation is supported by an educational grant from
Astellas

Description:
Overactive bladder (OAB) is a highly prevalent condition that approximately 17% of women and 16% of men over 18 suffer from, that’s an estimated 33 million people; however the numbers may be higher due to undiagnosed cases. OAB occurs about twice as frequently in women as in men, and while OAB is not considered a normal part of aging, it does become more prevalent with advanced age. OAB has a significant impact on quality of life (QoL), co-morbidities and cost; sufferers are two to three times more likely to experience disturbed sleep, overeating, poor self-esteem, and depression. Despite its impact, OAB remains underdiagnosed and undertreated. Screening and evaluating patients are of utmost importance in order to improve diagnosis and patient QoL. There are a variety of treatments available and typically a stepwise progression is implemented in OAB management. Multiple options of treatment are available in each line of therapy which provide for a tailored approach. This method allows for an individualized treatment plan based upon a patient’s expectations and goals for treatment, their co-morbidities, symptoms, and medication side-effects. What works and does not work will vary patient to patient, and it’s important to keep communications open to determine if a patient is unable to remain compliant to treatment due to side-effects or cost.

Upon completion of this activity, participants will be able to:

  • Explore barriers that prevent patients from receiving diagnosis and effective treatment of overactive bladder (OAB)

  • Review the principles of physiology and pharmacotherapy for currently available agents, including the antimuscarinics, beta-3 agonists and combination therapy

  • Implement strategies to engage in more effective patient, provider and payer dialogues to identify the patient’s needs and improve outcomes for OAB

  • Analyze benefit design strategies for clinicians and managed care professionals to improve overall patient outcomes in OAB

  • Discuss more effective patient dialogues to identify the patient’s needs and improve outcomes for OAB

     

Faculty: David Ginsberg, MD
Clinical Professor of Urology
USC-Keck School of Medicine

Disclosure:

Dr. Ginsberg serves on an advisory board for Urovant. His presentation has been peer reviewed for any bias.
  Planning Committee:
Bill Williams, MD has no relevant financial relationships to disclose.
Jeremy Williams has no relevant financial relationships to disclose.
Will Williams has no relevant financial relationships to disclose.
Jacqueline Cole, RN, MS, CMCN has no relevant financial relationships to disclose.

NAMCP and/or the presenter has copyright or has received permissions for use of materials provided in this activity.

Accreditation & Designation
The National Association of Managed Care Physicians (NAMCP) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

NAMCP designates this enduring material for a maximum of 1 AMA PRA Category 1 creditsTM.

The American Association of Managed Care Nurses (AAMCN) is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

Nurses who complete this activity and achieve a passing score will receive 1 hour in continuing
nursing credit.

This activity has been approved by the American Board of Managed Care Nursing for 1.0 contact hour toward CMCN recertification requirements.

This presentation is supported by an educational grant from
Astellas

NAMCP and/or this website does not provide medical advice, diagnosis or treatment. NAMCP does not endorse or imply endorsement of the content on any linked website. This website is to be used as an informational resource. With any health related concern, consult with your physician or healthcare professional.

Click Here To Continue